Sumitomo Dainippon Pharma U.S.-based unit enters agreement to divest asthma and allergy products to Covis pharma
July 14 (Reuters) - Sumitomo Dainippon Pharma Co Ltd :* Says its U.S.-based unit Sunovion Pharmaceuticals Inc. has.* The transaction is expected to close during the first half of Fiscal Year 2017, subject to customary closing conditions.
June 23 (Reuters) - FMC Corp -:FMC Corporation announces definitive agreement to sell omega-3 business to pelagia as.FMC Corp - terms of transaction were not disclosed..FMC Corp - transaction is expected to close by end of q3 2017.
June 11 (Reuters) - Paints And Chemical Industries Co Sae :Nine-month consol net profit after tax EGP 89.4 million versus EGP 58.3 million year ago.Nine-month consol net sales EGP 584.9 million versus EGP 617.1 million year ago.
Restructuring & Reorganization
No related earnings announcements are currently scheduled within the next 7 days.